We report the case of a patient with cutaneous and arthropathic psoriasis for eight years, whose sudden increased severity of the clinical picture led to a diagnosis of AIDS, emphasizing the importance of the specialist in the diagnosis of systemic diseases. The appropriate therapeutic interventions, including antiretroviral therapy and the immunobiological agent etanercept, enabled rapid improvement of symptoms and quality of life of the patient, besides contributing to delay in immunodeficiency progression. Keywords: Acquired immunodeficiency syndrome; Arthritis psoriatic; Psoriasis; Therapeutics Resumo: Relata-se o caso de um paciente com psoríase cutânea e artropática há oito anos, cujo agravamento súbito do quadro clínico levou ao diagnóstico da Aids, ressaltando a importância do especialista no diagnóstico de doenças sistêmicas. A intervenção terapêutica apropriada, incluindo a terapia antirretroviral e agente imunobiológico -etanercepte -possibilitou a rápida melhora do quadro clínico e da qualidade de vida do paciente, além de contribuir para o retardo na progressão da imunodeficiência.
INTRODUCTION
Psoriasis is a chronic inflammatory disease that affects from 2 to 3% of the worldwide population, frequently involving the skin and articulations. Its etiology is multifactorial, with participation of genetic, autoimmune and environmental factors. More recently the role of cells and inflammatory mediators in the pathogenesis of the disease was demonstrated and it is now defined as a systemic inflammatory affection of autoimmune nature 1 . The inflammatory symptom complex of psoriasis may be exacerbated by environmental factors, including viral infections, mainly HIV infection.
2 Articular involvement may take place in 6 to 42% of patients with skin psoriasis, with variable spectra, from non-erosive to severe and debilitating arthritis. Such clinical pictures should be differentiated from reactive arthritis, which is characterized by the triad polyarthritis, urethritis and conjunctivitis, together with the typical skin lesions. Studies also show that in patients with HIV/AIDS, articular involvement is usually more extensive and refractory to the customary therapy. 
▲ CASE REPORT

CASE REPORT
Clinical Picture: A 32-year-old male patient, single, was diagnosed with cutaneous and arthropathic psoriasis in 2002. As the skin lesions regressed soon after the beginning of treatment, the patient was monitored only through rheumatology, using methotrexate (MTX), 15mg/week, since the diagnosis (cumulative doses of 5040mg), with good clinical control of the disease. In June 2009, new skin lesions appeared, associated with marked recrudescence of the articular involvement and 10kg weight loss. The onset of skin lesions was the motive for referral to dermatology. Dermatological examination: presence of erythematous-squamous plaques, some of them with crusts, predominantly in the inguinal, palmo-plantar regions and back of hands (Figure 1 ). Articular Examination: arthritis in the proximal and distal interphalangeal articulations of hands, metacarpophalangeal articulations, wrists and thigh-femoral articulations. At the initial examination, PASI (Psoriasis Area and Severity Index) score was 19 ( Figure 2 ). Supplementary tests: positive serology for HIV, with a T CD4+ cell count of 217 cells/mm 3 and viral load of 11,000 copies/mm 3 . Negative VDRL. Radiography with varied alterations in small and large articulations, decreased articular spaces and formation of osteophytes. Computerized tomography (CT) revealed sclerosis, cortical irregularity, marginal osteophytes in the sacroiliac joints and bilateral acetabular cortical irregularity. Normal bone densitometry. Reactive Protein C: 12. Negative serology for Chlamydia trachomatis IgG and IgM. Rheumatoid factor negative. HLA B27 antigen search negative. Ophthalmological examination normal, ruling out uveitis. Histopathology compatible with psoriasis. Conduct: MTX suspended and acitretin introduced at the dosage of 30mg/day, associated with antiretroviral therapy (zidovudine, lamivudine, lopinavir and ritonavir). Progression: After 60 days of treatment, new lesions appeared on the trunk, nail lesions worsened, with onychodystrophy, onycholysis and "oil stains" on all 20 nails, with great exacerbation of the articular picture, severe arthritis of large and small articulations, in addition to pain that was refractory to powerful analgesia, making it impossible to walk and perform simple daily tasks (Figure 2 ). At this time, PASI was 29. This clinical recrudescence determined the introduction of etanercept, at an induction dose of 50mg 2x per week, with a maintenance dose of 50mg per week. After 60 days of treatment, there was significant improvement of the cutaneous-articular symptom complex, with a PASI of 6.9 (Figure 3) . The patient continues to be monitored through dermatology and infectology, using antiretrovirals and etanercept, without skin lesions and with significant improvement of the articular symptoms.
DISCUSSION
Since the beginning of the AIDS epidemic, a worsening of psoriasis progression is observed in patients with HIV infection, with sudden exacerbation of the clinical picture, onset of extensive cutaneous lesions, ungual and palmo-plantar expressive involvement, in addition to more aggressive articular affec- The differential diagnosis of articular manifestations should be done with reactive arthritis, characterized by the presence of the triad polyarthritis, urethritis and conjunctivitis, accompanied by the typical skin lesions. It affects more often young men and is a characteristic of association with HLA-B27, which is present in around 80-90% of patients. 7 In the case reported, the absence of urethritis and uveitis, as well as the negative results of the search for HLA B-27 and serology for Chlamydia trachomatis rule out the diagnosis.
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